Ana Martinez Selected Research

tau-tubulin kinase

1/2022	TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy.
1/2019	Tau Tubulin Kinase 1 (TTBK1), a new player in the fight against neurodegenerative diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Martinez Research Topics

Disease

19	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2002
16	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2002
7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 11/2011
7	Parkinson Disease (Parkinson's Disease) 12/2020 - 02/2011
6	Brain Injuries (Brain Injury) 05/2017 - 12/2009
5	Neuroinflammatory Diseases 01/2021 - 01/2011
5	Cognitive Dysfunction 01/2018 - 03/2013
4	COVID-19 01/2022 - 11/2020
4	Nervous System Diseases (Neurological Disorders) 03/2014 - 07/2007
4	Inflammation (Inflammations) 09/2013 - 07/2002
3	Fibrosis (Cirrhosis) 01/2020 - 09/2017
3	Neoplasms (Cancer) 06/2017 - 07/2002
3	Stroke (Strokes) 10/2016 - 07/2002
3	Brain Diseases (Brain Disorder) 01/2016 - 05/2007
3	Infections 11/2011 - 10/2007
3	HIV Infections (HIV Infection) 09/2009 - 06/2003
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021 - 01/2019
2	Chronic Disease (Chronic Diseases) 01/2020 - 01/2017
2	Fragile X Syndrome (Martin Bell Syndrome) 07/2018 - 01/2017
2	Ischemia 05/2017 - 10/2016
2	Gliosis 05/2017 - 12/2009
2	Hypoxia (Hypoxemia) 05/2017 - 10/2016
2	Schizophrenia (Dementia Praecox) 01/2016 - 01/2013
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2013 - 04/2012
2	Mood Disorders (Mood Disorder) 02/2012 - 09/2008
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2005 - 03/2004
1	Adenocarcinoma 01/2022
1	Diplopia (Double Vision) 04/2021
1	Myasthenia Gravis 04/2021
1	Proteostasis Deficiencies 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Rhinitis 01/2021
1	Ebola Hemorrhagic Fever 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2021

Drug/Important Bio-Agent (IBA)

12	Glycogen Synthase Kinase 3IBA 01/2022 - 07/2002
9	EnzymesIBA 12/2020 - 01/2006
8	Pharmaceutical PreparationsIBA 11/2020 - 10/2007
7	Glycogen Synthase (Synthase I)IBA 01/2022 - 01/2011
7	Phosphotransferases (Kinase)IBA 01/2022 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2014
5	Amyloid (Amyloid Fibrils)IBA 12/2018 - 01/2006
5	Type 7 Cyclic Nucleotide PhosphodiesterasesIBA 06/2015 - 02/2011
4	Protein Kinases (Protein Kinase)IBA 04/2021 - 01/2011
4	Biological ProductsIBA 04/2021 - 01/2011
4	Neuroprotective AgentsIBA 05/2017 - 05/2007
3	VaccinesIBA 01/2022 - 11/2011
3	Glycogen Synthase KinasesIBA 11/2019 - 05/2017
3	Cholinergic Agents (Cholinergics)IBA 10/2017 - 02/2002
2	tau-tubulin kinaseIBA 01/2022 - 01/2019
2	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2021
2	Nuclear Proteins (Protein, Nuclear)IBA 01/2021 - 01/2019
2	Leucine (L-Leucine)FDA Link 12/2020 - 09/2017
2	AlkaloidsIBA 01/2020 - 07/2006
2	CytokinesIBA 01/2019 - 03/2016
2	Acetylcholine (Acetylcholine Chloride)FDA Link 12/2018 - 01/2006
2	Peptides (Polypeptides)IBA 12/2018 - 09/2013
2	Adenosine Monophosphate (AMP)IBA 01/2018 - 03/2014
2	tau Proteins (tau Protein)IBA 01/2018 - 09/2013
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2017 - 01/2006
2	Therapeutic UsesIBA 01/2017 - 07/2002
2	tideglusibIBA 10/2016 - 05/2007
2	diethylstilbestrol monophosphate (PDES)IBA 01/2016 - 01/2011
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 02/2015 - 03/2014
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2014 - 03/2013
2	Amyloid beta-PeptidesIBA 09/2013 - 10/2008
2	Kainic Acid (Kainate)IBA 12/2009 - 05/2007
2	Glutamate Receptors (Glutamate Receptor)IBA 11/2003 - 02/2002
1	Messenger RNA (mRNA)IBA 01/2022
1	Proteolysis Targeting ChimeraIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Autophagy-Related Protein-1 HomologIBA 01/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	phosphatidylethanolamineIBA 01/2022
1	AMP-Activated Protein KinasesIBA 01/2022
1	phosphatidylinositol 3-phosphateIBA 01/2022
1	maleimideIBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	Class III Phosphatidylinositol 3-KinasesIBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Neutralizing AntibodiesIBA 05/2021
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 04/2021
1	Protein AggregatesIBA 01/2021
1	2-mercaptopurineIBA 01/2021
1	UbiquitinIBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Protein Kinase InhibitorsIBA 01/2021
1	CurcuminIBA 01/2020
1	hemanthamineIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	EstersIBA 01/2020

Therapy/Procedure

13	Therapeutics 01/2022 - 11/2003
3	Drug Therapy (Chemotherapy) 01/2006 - 02/2002
2	Ligation 05/2017 - 10/2016
1	Long-Term Care 01/2022
1	Immunotherapy 01/2021